Enacademic 🎓Analogindex

From the interestingasfuck community on Reddit: Blacking out the screen everytime a mobile phone driver is not looking at the road

Blacking out the screen everytime a mobile phone driver is not looking at the road

submitted by /u/Rooonaldooo99 to r/interestingasfuck link comments
Read more...

Explore this post and more from the interestingasfuck community

1 viewFormato a Mensajes, 17:59

*Why political ads are helping keep X afloat*

It's not secret that Elon Musk has been bleeding advertisers at X, formerly known as Twitter, since his purchase of the platform in late 2022. Since he brought a sink into Twitter headquarter to let the world know that he was in charge of place after paying an estimated $44 billion for the social media company, Musk has made wholesale changes from everything to the company's name to the way it policies and regulates content on the platform. Related: Macy's stock soars Monday - What we know about a reported takeover offer A bevy of advertisers like Disney (DIS) - Get Free Report, Apple (AAPL) - Get Free Report and IBM (IBM) - Get Free Report have paused their advertising on the site following a report from Media Matters showing that advertisements were being shown next to popular neo-nazi accounts on the platform. The message was clear: no one wants their advertisements next to proto-nazis tweeting nonsense from their mother's basements. Elon Musk also had a clear message for the advertisers that left (and that he still needs to make Twitter work): "go fuck yourself." Despite the bluster from that interview, Musk also tipped his hand about the future of the platform, declaring during that same interview that "this advertising boycott is going to kill the company." But, at least for the time being, Musk and X are getting a bit of a reprieve from an unexpected source: Democrat political candidates. 2024 is a major election year, and politicians have money to spend on advertising. And despite their disparate political ideologies, Democrats are throwing a lot of money Musk's way these days. Democrats have spent over a million dollars to run thousands of political ads on X, according to an analysis of the company's ad disclosure data by the Washington Post. Reps. Dan Goldman (D-NY) and Adam Schiff (D-CA) and 24 of their colleagues signed a letter in November saying that X is guilty of the "promotion of misinformation and hateful, violent, and terroristic propaganda videos, which shockingly have been used by the company for profit." While that message certainly resonates with voters on the left who have seen Musk go further to the right side of the political spectrum in recent years — though he has said that the left wing of the Democratic party has moved further left while he has stayed the same — in reality, Schiff, Goldman and more than 50 other Democratic political candidates are keeping X alive with their political ads. Schiff in particular spent over $90,000 on X advertisements the month before publishing the letter. The Post report points out that Republicans are also heavy advertisers on X, but at least there is ideological consistency there. Musk and X opened former Fox News host Tucker Carlson with open arms after he was unceremoniously fired from his top-rated TV news program. Get exclusive access to portfolio managers’ stock picks and proven investing strategies with Real Money Pro. Get started now.
[Read more...](https://www.thestreet.com/social-media/politcal-ads-on-x-from-democrats)

Elon Musk is getting a much-needed lifeline from an unexpected source

X, formerly known as Twitter, is bleeding advertisers from many business sectors, but one group is spending big heading into 2024.

1 viewRSS Bot - Chat automation, 17:59

Why political ads are helping keep X afloat

It's not secret that Elon Musk has been bleeding advertisers at X, formerly known as Twitter, since his purchase of the platform in late 2022. Since he brought a sink into Twitter headquarter to let the world know that he was in charge of place after paying an estimated $44 billion for the social media company, Musk has made wholesale changes from everything to the company's name to the way it policies and regulates content on the platform. Related: Macy's stock soars Monday - What we know about a reported takeover offer A bevy of advertisers like Disney (DIS) - Get Free Report, Apple (AAPL) - Get Free Report and IBM (IBM) - Get Free Report have paused their advertising on the site following a report from Media Matters showing that advertisements were being shown next to popular neo-nazi accounts on the platform. The message was clear: no one wants their advertisements next to proto-nazis tweeting nonsense from their mother's basements. Elon Musk also had a clear message for the advertisers that left (and that he still needs to make Twitter work): "go fuck yourself." Despite the bluster from that interview, Musk also tipped his hand about the future of the platform, declaring during that same interview that "this advertising boycott is going to kill the company." But, at least for the time being, Musk and X are getting a bit of a reprieve from an unexpected source: Democrat political candidates. 2024 is a major election year, and politicians have money to spend on advertising. And despite their disparate political ideologies, Democrats are throwing a lot of money Musk's way these days. Democrats have spent over a million dollars to run thousands of political ads on X, according to an analysis of the company's ad disclosure data by the Washington Post. Reps. Dan Goldman (D-NY) and Adam Schiff (D-CA) and 24 of their colleagues signed a letter in November saying that X is guilty of the "promotion of misinformation and hateful, violent, and terroristic propaganda videos, which shockingly have been used by the company for profit." While that message certainly resonates with voters on the left who have seen Musk go further to the right side of the political spectrum in recent years — though he has said that the left wing of the Democratic party has moved further left while he has stayed the same — in reality, Schiff, Goldman and more than 50 other Democratic political candidates are keeping X alive with their political ads. Schiff in particular spent over $90,000 on X advertisements the month before publishing the letter. The Post report points out that Republicans are also heavy advertisers on X, but at least there is ideological consistency there. Musk and X opened former Fox News host Tucker Carlson with open arms after he was unceremoniously fired from his top-rated TV news program. Get exclusive access to portfolio managers’ stock picks and proven investing strategies with Real Money Pro. Get started now.
Read more...

Elon Musk is getting a much-needed lifeline from an unexpected source

X, formerly known as Twitter, is bleeding advertisers from many business sectors, but one group is spending big heading into 2024.

1 viewFormato a Mensajes, 17:59

*Eli Lilly slumps after disappointing Zepbound weight-loss-drug trial*

Eli Lilly (LLY) - Get Free Report shares slumped Monday after it posted data from a trial of its Zepbound obesity treatment showing patients gained substantial weight when they stopped taking the new drug. Eli Lilly said patients given regular injections of of trizepatide, which the drugmaker brands as Zepbound, benefited from an average weight loss of around 20.9% from a starting average of around 236.6 pounds over the course of the 36-week study. However, once the treatment ended and patients were switched to a placebo, they saw an average weight regain of around 14.8% over the following year. Those who continued with the drug lost another 5.5% in weight, according to data from the Surmount-4 study published in the Journal of the American Medical Association. "Patients, providers and the public do not always understand obesity is a chronic disease that often requires ongoing treatment, which can mean that treatment is stopped once weight goals are met," said Eli Lilly's senior vice president for product development, Jeff Emmick. "However, studies like Surmount-4 show that continued therapy can help people living with obesity maintain their weight loss." Lilly Q3 was stronger than expected Eli Lilly shares were marked 3.9% lower at last check following publication of the trial results to change hands at $574.73. The move still leaves the stock up nearly 30% over the past six months. Last month Lilly posted better-than-expected third-quarter earnings thanks to the ongoing surge in sales for Mounjaro, its anti-obesity drug targeted for type-2 diabetes sufferers. That strength offset a slump in revenue for its legacy diabetes treatment Trulicity. Trulicity saw sales fell 10% from a year earlier to $1.67 billion while Taltz, its drug that fights severe plaque psoriasis, saw sales rise 9% to $744.2 million. Mounjaro and Zepbound, which Eli Lilly hopes can challenge the early market dominance of Novo Nordisk's Ozempic, produced sales of $1.41 billion. Looking into the current financial year, Eli Lilly said non-GAAP earnings would likely slow to between to between $6.50 and $6.70 per share. That's down from its prior forecast of $9.70 to $9.90 per share, thanks in part to a surge in in-process research and development costs.Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
[Read more...](https://www.thestreet.com/investing/stocks/eli-lilly-slumps-after-disappointing-zepbound-weight-loss-drug-trial)

Eli Lilly slumps after disappointing Zepbound weight-loss-drug trial

Zepbound, which Eli Lilly had hoped would offset the slide in Trulicity sales, had mixed results in a major clinical trial.

1 viewRSS Bot - Chat automation, 17:59

Eli Lilly slumps after disappointing Zepbound weight-loss-drug trial

Eli Lilly (LLY) - Get Free Report shares slumped Monday after it posted data from a trial of its Zepbound obesity treatment showing patients gained substantial weight when they stopped taking the new drug. Eli Lilly said patients given regular injections of of trizepatide, which the drugmaker brands as Zepbound, benefited from an average weight loss of around 20.9% from a starting average of around 236.6 pounds over the course of the 36-week study. However, once the treatment ended and patients were switched to a placebo, they saw an average weight regain of around 14.8% over the following year. Those who continued with the drug lost another 5.5% in weight, according to data from the Surmount-4 study published in the Journal of the American Medical Association. "Patients, providers and the public do not always understand obesity is a chronic disease that often requires ongoing treatment, which can mean that treatment is stopped once weight goals are met," said Eli Lilly's senior vice president for product development, Jeff Emmick. "However, studies like Surmount-4 show that continued therapy can help people living with obesity maintain their weight loss." Lilly Q3 was stronger than expected Eli Lilly shares were marked 3.9% lower at last check following publication of the trial results to change hands at $574.73. The move still leaves the stock up nearly 30% over the past six months. Last month Lilly posted better-than-expected third-quarter earnings thanks to the ongoing surge in sales for Mounjaro, its anti-obesity drug targeted for type-2 diabetes sufferers. That strength offset a slump in revenue for its legacy diabetes treatment Trulicity. Trulicity saw sales fell 10% from a year earlier to $1.67 billion while Taltz, its drug that fights severe plaque psoriasis, saw sales rise 9% to $744.2 million. Mounjaro and Zepbound, which Eli Lilly hopes can challenge the early market dominance of Novo Nordisk's Ozempic, produced sales of $1.41 billion. Looking into the current financial year, Eli Lilly said non-GAAP earnings would likely slow to between to between $6.50 and $6.70 per share. That's down from its prior forecast of $9.70 to $9.90 per share, thanks in part to a surge in in-process research and development costs.Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
Read more...

Eli Lilly slumps after disappointing Zepbound weight-loss-drug trial

Zepbound, which Eli Lilly had hoped would offset the slide in Trulicity sales, had mixed results in a major clinical trial.

1 viewFormato a Mensajes, 17:59

From the MadeMeSmile community on Reddit: Daughter’s face changed when she saw sees her parents in the crowd

*Daughter’s face changed when she saw sees her parents in the crowd*

submitted by /u/Bihema to r/MadeMeSmile [link] [comments]
[Read more...](https://www.reddit.com/r/MadeMeSmile/comments/18fsqco/daughters_face_changed_when_she_saw_sees_her/)

Explore this post and more from the MadeMeSmile community

1 viewRSS Bot - Chat automation, 18:28

From the MadeMeSmile community on Reddit: Daughter’s face changed when she saw sees her parents in the crowd

Daughter’s face changed when she saw sees her parents in the crowd

submitted by /u/Bihema to r/MadeMeSmile link comments
Read more...

Explore this post and more from the MadeMeSmile community

1 viewFormato a Mensajes, 18:28

*A Dermatologist Says This Thing Should Be Cleaned Often to Avoid Viruses*

This tip forever changed my laundry routine. READ MORE...
[Read more...](https://www.apartmenttherapy.com/clean-hand-towels-to-avoid-virus-warts-37352709?utm_source=RSS&utm_medium=feed&utm_campaign=Category%2FChannel%3A+main)

1 viewRSS Bot - Chat automation, 18:28

*10 стыдных вопросов о психическом здоровье: отвечает психиатр Кирилл Сычёв*

Мы собрали то, о чём вы так хотели узнать, но стеснялись спросить.
[Read more...](https://lifehacker.ru/stydnye-voprosy-o-psihicheskom-zdorovie/)

1 viewRSS Bot - Chat automation, 18:29

*Retroid 4 handheld game console coming soon for $149 and up, with Dimensity 900 &1100 processor options*

The upcoming Retroid Pocket 4 is a handheld game system with a 4.7 inch HD display, 128GB of UFS 3.1 storage, a microSD card reader, support for WiFi 6 and Bluetooth 5.2, and a 5,000 mAh battery. Designed for retro gaming, the handheld also features hall sensor joysticks and analog triggers. And it will be […] The post Retroid 4 handheld game console coming soon for $149 and up, with Dimensity 900 &1100 processor options appeared first on Liliputing.
[Read more...](https://liliputing.com/retroid-4-handheld-game-console-coming-soon-for-149-and-up-with-dimensity-900-1100-processor-options/)

1 viewRSS Bot - Chat automation, 18:29